Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New painkiller tested for abuse risk – could it be safer than oxycodone?

NCT ID NCT06453265

First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 28 times

Summary

This study tested a new painkiller called cebranopadol to see how much people like it compared to oxycodone and a placebo when snorted. It involved 48 healthy adults who had used opioids for fun before. The goal was to measure abuse potential, which helps understand if the drug might be less addictive.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABUSE, DRUG are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ohio Clinical Trials, Inc.

    Columbus, Ohio, 43212, United States

Conditions

Explore the condition pages connected to this study.